Talk to the people behind the exciting things we do at Bidwells.

Our people

loader
    Sorry, there were no results for your search. Please try again loader
      Oxford to Cambridge Arc
      What we do/ Oxford to Cambridge Arc

      Oxford to Cambridge Arc

      We are the leading property consultancy in the Arc. Our deep understanding of the region and unrivalled knowledge of its markets are the source of our ability to unlock value.

      International investors are being drawn like a magnet by the Arc’s world-leading universities and its innovative businesses, while the Government continues to support large-scale growth in the region.

      At Bidwells, we believe the Arc will shape the UK’s future; setting an example of how truly sustainable economic growth should be delivered.

      OPPORTUNITIES ACROSS THE ARC

      The Arc is a high-growth region of global significance

      A Green Arc

      Good Growth

      Sustainable Development

      National Leadership, Local Delivery

      A GREEN ARC

      Local and national Government leaders have committed to doubling nature across the Arc.

      By protecting, restoring and enhancing our biodiversity and natural capital assets, it can be done.
      GOOD GROWTH

      The knowledge economy is not driven simply by a chase for growth.

      But by an academic push to combat the universal challenges threatening our planet.
      Sustainable Development

      We are advising on developments across the Arc with a value of over £56bn.

      Leading the way in delivering sustainable, mixed-use communities and urban centres.
      National Leadership, Local Delivery

      A single planning framework for the Arc will help direct investment into employment space, improved transport links and new housing – a real game changer.

      PODCAST

      We’re all epidemiologists now. Can AstraZeneca and Oxford Uni inspire a generation of Ox-Cam Arc placemakers?

      Episode Summary
      News of AstraZeneca’s recent Covid-19 partnership agreement with the University of Oxford echoed around the world. The deal would see the Cambridge-based pharmaceutical giant producing billions of doses of a vaccine currently being trialled at The Jenner Institute in Oxford, at no profit, and effectively bring an end to the global crisis.

      Featured articles

      OUR ADVISORS

      Looking to discuss the Oxford to Cambridge Arc?

      Spread the word